Beta-thalassemia primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2]

Overview

Primary prevention strategies are carrier screening, genetic counseling, and prenatal testing to identify at-risk couples and provide appropriate guidance regarding family planning options.

Primary Prevention

Primary prevention strategies are:

Carrier screening
Genetic counseling
Prenatal testing

to identify at-risk couples and provide appropriate guidance regarding family planning options^[1]^[2]. .

References

↑ Ali S, Mumtaz S, Shakir HA, Khan M, Tahir HM, Mumtaz S, Mughal TA, Hassan A, Kazmi S, Sadia, Irfan M, Khan MA (December 2021). “Current status of beta-thalassemia and its treatment strategies”. Mol Genet Genomic Med. 9 (12): e1788. doi:10.1002/mgg3.1788. PMC 8683628 Check |pmc= value (help). PMID 34738740 Check |pmid= value (help). Vancouver style error: initials (help)
↑ Khandros E, Kwiatkowski JL (June 2019). “Beta Thalassemia: Monitoring and New Treatment Approaches”. Hematol Oncol Clin North Am. 33 (3): 339–353. doi:10.1016/j.hoc.2019.01.003. PMID 31030806.

Template:WikiDoc Sources

[pmid34738740-1] Ali S, Mumtaz S, Shakir HA, Khan M, Tahir HM, Mumtaz S, Mughal TA, Hassan A, Kazmi S, Sadia, Irfan M, Khan MA (December 2021). “Current status of beta-thalassemia and its treatment strategies”. Mol Genet Genomic Med. 9 (12): e1788. doi:10.1002/mgg3.1788. PMC 8683628 Check |pmc= value (help). PMID 34738740 Check |pmid= value (help). Vancouver style error: initials (help)

[pmid31030806-2] Khandros E, Kwiatkowski JL (June 2019). “Beta Thalassemia: Monitoring and New Treatment Approaches”. Hematol Oncol Clin North Am. 33 (3): 339–353. doi:10.1016/j.hoc.2019.01.003. PMID 31030806.

[1]

[2]

Beta-thalassemia primary prevention

Overview

Primary Prevention

References

Looking for the patient version?